TASIGNA
Dead / Cancelled — Cancelled — Section 8 (as of 12 Oct 2012)
What this means for you
This registration has been cancelled; it no longer blocks anyone on its own. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 78458843
- Registration number
- 2995313
- Mark type
- Stylized text
- Filed
- 29 Jul 2004
- Published for opposition
- 21 Jun 2005
- Registered
- 13 Sept 2005
- Attorney of record
- MAURY M. TEPPER, III
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the prevention and treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the respiratory system, the musculo-skeletal system, the genitourinary system, for the treatment of inflammatory disorders, for use in dermatology, in oncology, in hematology, in transplantation, in ophthalmology, for use in the gastroenterological area and the prevention and treatment of ocular disorders or diseases; anti-infectives, pharmaceutical preparations treating bacteria-based diseases, antivirals, anti-biotics, anti-fungals
Owner
- Novartis AG, Basel, CH
- Novartis AG, Basel, CH
- Novartis AG, Basel, CH
Prosecution history
- 12 Oct 2012 — CANCELLED SEC. 8 (6-YR)
- 19 Jun 2009 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 13 Sept 2005 — REGISTERED-PRINCIPAL REGISTER
- 21 Jun 2005 — PUBLISHED FOR OPPOSITION
- 01 Jun 2005 — NOTICE OF PUBLICATION
- 10 Mar 2005 — LAW OFFICE PUBLICATION REVIEW COMPLETED
- 07 Mar 2005 — ASSIGNED TO LIE
- 02 Mar 2005 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 01 Mar 2005 — EXAMINERS AMENDMENT E-MAILED
- 01 Mar 2005 — EXAMINERS AMENDMENT -WRITTEN
- 25 Feb 2005 — PRIORITY ACTION E-MAILED
- 25 Feb 2005 — PRIORITY ACTION WRITTEN
- 23 Feb 2005 — ASSIGNED TO EXAMINER
- 21 Dec 2004 — AMENDMENT FROM APPLICANT ENTERED
- 06 Dec 2004 — UNRESPONSIVE/DUPLICATE PAPER RECEIVED